Prosecution Insights
Last updated: October 02, 2026
Application No. 18/740,868

DEVICES, SYSTEMS, AND METHODS FOR PREVENTING ARCING BETWEEN ELECTRODES FOR MEDICAL PROCEDURES

Non-Final OA §102
Filed
Jun 12, 2024
Priority
Jun 13, 2023 — provisional 63/472,711
Examiner
DEMIE, TIGIST S
Art Unit
3794
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Boston Scientific Corporation
OA Round
1 (Non-Final)
75%
Grant Probability
Favorable
1-2
OA Rounds
11m
Est. Remaining
96%
With Interview

Examiner Intelligence

Grants 75% — above average
75%
Career Allowance Rate
343 granted / 457 resolved
+5.1% vs TC avg
Strong +21% interview lift
Without
With
+20.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
42 currently pending
Career history
486
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
49.1%
+9.1% vs TC avg
§102
25.6%
-14.4% vs TC avg
§112
19.0%
-21.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 457 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant's election with traverse of Group I and Species D in the reply filed on 07/22/2026 is acknowledged. The traversal is on the ground(s) that Species A of fig.1 and fig 1A being generic to fig.2-12 . That argument is persuasive and the examiner acknowledges fig.1 and 1A being generic to fig.2-12. . Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1,2, 12-13 are rejected under 35 U.S.C. 102 (a) (1) as being anticipated by Moss et al. (US 2020/0323588). Regarding claim 1, an energy-delivering assembly comprising: an energy-delivering member (fig.1; energy delivery probe 1) formed of an electrically-conductive material (fig.1; electrode 21, 41, 51); an electrode-defining insulation member (fig.1; insulating region 2, 20) positioned over a portion of said energy-delivering member to define a first electrode spaced apart from a second electrode by said electrode-defining insulation member (fig.3, see also [0068]); and at least one arc-reducing interface between said electrode-defining insulation member and an adjacent one of said first and second electrodes (fig.3, see also [0068]). Regarding claim 2, the energy-delivering assembly of claim 1, wherein said arc-reducing interface comprises a region comprises a modified shape of at least one of said electrode-defining insulation member or said adjacent one of said first and second electrodes (fig.4B-D, see [0073]). Regarding claim 12, the energy-delivering assembly of claim 1, wherein said first electrode and said second electrode are colinear to define said energy-delivering assembly as a bipolar linear probe (fig.2, see also [0063]). Regarding claim 13, Moss discloses an energy-delivering treatment system comprising: an energy-delivering assembly comprising: an energy-delivering member (fig.1; electrode 21, 41, 51) formed of an electrically-conductive material [0076]; an electrode-defining insulation member (fig.3; insulating regions 2, 20) positioned over a portion of said energy- delivering member to define a first electrode spaced apart from a second electrode by said electrode-defining insulation member (fig.3,see also [0068]); and at least one arc-reducing interface between said electrode-defining insulation member (fig.3;see also [0068]) and an adjacent one of said first and second electrodes (fig.3;see also [0068]); and a power connector configured to deliver energy to said energy-delivering assembly to deliver energy to said energy-delivering member to deliver energy along said electrodes thereof (fig.1; energy source 29, see also [0073]). Claims 1-2, 4, 12-14 are rejected under 35 U.S.C. 102 (a)(1) as being anticipated by Koop et al. (US 2022/0378502). Regarding claim 1, Koop discloses an energy-delivering assembly comprising: an energy-delivering member (fig.2B; ablation catheter 200) formed of an electrically-conductive material (fig.1; electrode assembly 202); an electrode-defining insulation member (fig.2B; insulating region 2, 20) positioned over a portion of said energy-delivering member to define a first electrode spaced apart from a second electrode by said electrode-defining insulation member [0085]; and at least one arc-reducing interface (fig.2B; rounded shape at the corners 226, 228, see also [0061]) between said electrode-defining insulation member and an adjacent one of said first and second electrodes (fig.2B, see also , [0061] and [0076]). Regarding claim 2, Koop discloses the energy-delivering assembly of claim 1, wherein said arc-reducing interface comprises a region comprises a modified shape of at least one of said electrode-defining insulation member or said adjacent one of said first and second electrodes [fig.2B; see also [0076]). Regarding claim 4, Koop discloses the energy-delivering assembly of claim 2, wherein said arc-reducing interface comprises a rolled wall of said first electrode adjacent said electrode-defining insulation member (fig.2B, see also [0061]). Regarding claim 12, Koop discloses the energy-delivering assembly of claim 1, wherein said first electrode and said second electrode are colinear to define said energy-delivering assembly as a bipolar linear probe (fig.2B, see also [0063]). Regarding claim 13, Koop discloses an energy-delivering treatment system comprising: an energy-delivering assembly comprising: an energy-delivering member (fig.1; electrode assembly 202) formed of an electrically-conductive material [0074]; an electrode-defining insulation member [0085] positioned over a portion of said energy- delivering member to define a first electrode spaced apart from a second electrode by said electrode-defining insulation member (fig.2B,see also [0085]); and at least one arc-reducing interface between said electrode-defining insulation member (fig.2B;see also [0085]) and an adjacent one of said first and second electrodes (fig.2B;see also [0085]); and a power connector configured to deliver energy to said energy-delivering assembly to deliver energy to said energy-delivering member to deliver energy along said electrodes thereof (fig.1; electroporation generator 130, see also [0084]). Regarding claim 14, Koop discloses the energy-delivering treatment system of claim 13, wherein said arc-reducing interface comprises a region comprises a modified shape of at least one of said electrode-defining insulation member or said adjacent one of said first and second electrodes (fig.2B, see also [0061]). The edges of the electrodes comprise modified shape as well (see fig.2B and [0076]) Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure: Mikus (US 2009/0281477 ) teaches an energy-delivering treatment system comprising: an energy-delivering assembly comprising: an energy-delivering member (fig.1; device 100) formed of an electrically-conductive material [0026]; an electrode-defining insulation member (insulating region 13, see also [0026]) positioned over a portion of said energy- delivering member to define a first electrode spaced apart from a second electrode by said electrode-defining insulation member (fig.4,see also [0036]); and at least one arc-reducing interface between said electrode-defining insulation member [0026] and an adjacent one of said first and second electrodes [0026]; and a power connector configured to deliver energy to said energy-delivering assembly to deliver energy to said energy-delivering member to deliver energy along said electrodes thereof [0029]. Any inquiry concerning this communication or earlier communications from the examiner should be directed to TIGIST S DEMIE whose telephone number is (571)270-5345. The examiner can normally be reached Monday-Friday 8am-5Pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Stoklosa can be reached at 571-2721213. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /TIGIST S DEMIE/Primary Examiner, Art Unit 3794
Read full office action

Prosecution Timeline

Jun 12, 2024
Application Filed
Aug 12, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12746055
MEDICAL DEVICE AND MEDICAL SYSTEM
3y 7m to grant Granted Sep 29, 2026
Patent 12746061
CATHETERS, SYSTEMS, AND METHODS FOR ENDOVACSULAR TREATMENT OF A BLOOD VESSEL
2y 6m to grant Granted Sep 29, 2026
Patent 12740890
METHOD FOR MANUFACTURING HEATING BODY, AND HEATING BODY
3y 7m to grant Granted Sep 22, 2026
Patent 12744504
CONFIGURABLE MULTI-POLAR RF ABLATION PROBE
3y 11m to grant Granted Sep 22, 2026
Patent 12740889
APPARATUS FOR THERMAL THERAPY TREATMENT OF A SELECTED REGION OF THE BODY OF A HUMAN OR OF AN ANIMAL AND METHOD OF OPERATING SAID APPARATUS
3y 4m to grant Granted Sep 22, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
75%
Grant Probability
96%
With Interview (+20.7%)
3y 2m (~11m remaining)
Median Time to Grant
Low
PTA Risk
Based on 457 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month